Atlas Trials

Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome

Clinical trial NCT04681417 · RECRUITING

Trial details

NCT number
NCT04681417
Sponsor
Institut Curie
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Retinoblastoma
Start date
2021-03-25
Primary completion
2035-01-20
Enrollment
225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.